A Phase 2, Open-label Trial of guadecitabine (SGI-110) in patients with T-cell Lymphoma

Shortt, Jake (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: HREC/17/MonH/555
Monash Health Ref: 17-0000-631A

Status	Active
Effective start/end date	3/06/19 → 2/06/24

Keywords

clinical trial
treatment efficacy
T-cell lymphoma